Shusei Hamamichi, Ph.D.

2009 Biological Sciences The University of Alabama, Tuscaloosa, AL 
"Shusei Hamamichi"
Mean distance: 17.84 (cluster 11)


Sign in to add mentor
Guy Caldwell grad student 2009 University of Alabama
 (Identification of neuroprotective genes against alpha-synuclein toxicity using a Caenorhabditis elegans Parkinson disease model.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gaeta AL, Nourse JB, Willicott K, et al. (2022) Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. Plos Genetics. 18: e1010115
Knight AL, Yan X, Hamamichi S, et al. (2014) The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models. Cell Metabolism. 20: 145-57
Matlack KE, Tardiff DF, Narayan P, et al. (2014) Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. Proceedings of the National Academy of Sciences of the United States of America. 111: 4013-8
Muñoz-Lobato F, Rodríguez-Palero MJ, Naranjo-Galindo FJ, et al. (2014) Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. Antioxidants & Redox Signaling. 20: 217-35
Treusch S, Hamamichi S, Goodman JL, et al. (2011) Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science (New York, N.Y.). 334: 1241-5
Liu Z, Hamamichi S, Lee BD, et al. (2011) Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Human Molecular Genetics. 20: 3933-42
Yacoubian TA, Slone SR, Harrington AJ, et al. (2010) Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2
Harrington AJ, Hamamichi S, Caldwell GA, et al. (2010) C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 1282-95
Su LJ, Auluck PK, Outeiro TF, et al. (2010) Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Disease Models & Mechanisms. 3: 194-208
Kritzer JA, Hamamichi S, McCaffery JM, et al. (2009) Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nature Chemical Biology. 5: 655-63
See more...